Published in Aging Dis on February 16, 2014
Mechanisms underlying the anti-aging and anti-tumor effects of lithocholic bile acid. Int J Mol Sci (2014) 0.82
Discovery of plant extracts that greatly delay yeast chronological aging and have different effects on longevity-defining cellular processes. Oncotarget (2016) 0.77
RAC3 more than a nuclear receptor coactivator: a key inhibitor of senescence that is downregulated in aging. Cell Death Dis (2015) 0.77
Inflamma-miRs in Aging and Breast Cancer: Are They Reliable Players? Front Med (Lausanne) (2015) 0.76
Six plant extracts delay yeast chronological aging through different signaling pathways. Oncotarget (2016) 0.76
A novel approach to the discovery of anti-tumor pharmaceuticals: searching for activators of liponecrosis. Oncotarget (2016) 0.76
Genomic deletion of GIT2 induces a premature age-related thymic dysfunction and systemic immune system disruption. Aging (Albany NY) (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (2009) 49.82
Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer (2002) 34.99
Autophagy in the pathogenesis of disease. Cell (2008) 34.68
A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A (1995) 32.89
mTOR signaling in growth control and disease. Cell (2012) 29.21
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell (1997) 29.13
The serial cultivation of human diploid cell strains. Exp Cell Res (1961) 25.11
NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A (2006) 21.58
mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol (2010) 21.16
The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab (2008) 18.87
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature (2007) 16.95
BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature (2005) 16.87
Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol (2007) 16.55
Mitochondria, oxidants, and aging. Cell (2005) 16.11
Met, metastasis, motility and more. Nat Rev Mol Cell Biol (2003) 14.30
The hallmarks of aging. Cell (2013) 14.29
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell (2005) 12.73
A DNA damage checkpoint response in telomere-initiated senescence. Nature (2003) 12.55
Extending healthy life span--from yeast to humans. Science (2010) 12.12
Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol (2008) 11.43
Role of the INK4a locus in tumor suppression and cell mortality. Cell (1996) 11.41
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell (2003) 11.40
Autophagy and the integrated stress response. Mol Cell (2010) 11.21
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature (2006) 11.18
Role of autophagy in cancer. Nat Rev Cancer (2007) 10.88
Cancer and the chemokine network. Nat Rev Cancer (2004) 10.27
Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell (2012) 9.88
Caloric restriction delays disease onset and mortality in rhesus monkeys. Science (2009) 9.84
Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell (2008) 9.22
Cellular senescence in cancer and aging. Cell (2007) 9.04
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature (2011) 8.45
Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol (2003) 8.42
Ink4a/Arf expression is a biomarker of aging. J Clin Invest (2004) 8.30
The essence of senescence. Genes Dev (2010) 8.21
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol (2009) 7.74
Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell (2008) 7.65
The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol (2010) 7.58
The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol (2012) 7.32
Four faces of cellular senescence. J Cell Biol (2011) 6.86
Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell (2008) 6.84
Autophagy mediates the mitotic senescence transition. Genes Dev (2009) 6.80
Lamin A-dependent nuclear defects in human aging. Science (2006) 6.71
Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell (2004) 6.48
Senescence in tumours: evidence from mice and humans. Nat Rev Cancer (2010) 6.34
The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol (2012) 6.07
How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol (2007) 5.80
Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov (2011) 5.79
Augmented Wnt signaling in a mammalian model of accelerated aging. Science (2007) 5.62
Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J (2003) 5.61
Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev (2006) 5.61
Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev (1998) 5.60
DNA repair, genome stability, and aging. Cell (2005) 5.52
Colorectal cancer: mutations in a signalling pathway. Nature (2005) 5.42
The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat Rev Mol Cell Biol (2013) 5.33
Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev (1998) 5.14
Aging, cellular senescence, and cancer. Annu Rev Physiol (2012) 5.08
Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer (2009) 5.02
The signals and pathways activating cellular senescence. Int J Biochem Cell Biol (2004) 5.00
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature (2009) 4.98
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature (2000) 4.90
Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat Cell Biol (2004) 4.87
Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev Cell (2005) 4.83
A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell (2006) 4.74
Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov (2013) 4.72
DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev (1994) 4.64
Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer (2008) 4.63
NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev (2008) 4.61
Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nat Cell Biol (2006) 4.54
The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther (2011) 4.39
Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem (1999) 4.38
Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature (2010) 4.36
The common biology of cancer and ageing. Nature (2007) 4.28
Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene (2008) 4.21
Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev (2008) 4.14
Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J Cell Sci (2005) 3.96
Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med (2010) 3.79
How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature (2012) 3.77
Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat Cell Biol (2006) 3.63
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health. Oncotarget (2011) 3.43
Lipid metabolism in cancer. FEBS J (2012) 3.42
Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor. Mol Cell Biol (2000) 3.37
Growth stimulation leads to cellular senescence when the cell cycle is blocked. Cell Cycle (2008) 3.37
Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol (2011) 3.36
PML is induced by oncogenic ras and promotes premature senescence. Genes Dev (2000) 3.35
Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proc Natl Acad Sci U S A (2008) 3.30
The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol (2010) 3.29
Feedback between p21 and reactive oxygen production is necessary for cell senescence. Mol Syst Biol (2010) 3.27
The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway. Aging (Albany NY) (2010) 3.27
Senescence-associated beta-galactosidase is lysosomal beta-galactosidase. Aging Cell (2006) 3.24
Age-related decline in chaperone-mediated autophagy. J Biol Chem (2000) 3.22
Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med (2001) 3.22
Accumulation of senescent cells in mitotic tissue of aging primates. Mech Ageing Dev (2006) 3.14
Molecular regulation of stem cell quiescence. Nat Rev Mol Cell Biol (2013) 3.07
The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res (2006) 3.07
Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence. J Biol Chem (2006) 3.00
LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiol (Oxf) (2009) 2.94
Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer Res (2007) 2.94
Protein quality control during aging involves recruitment of the macroautophagy pathway by BAG3. EMBO J (2009) 2.83
Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc Natl Acad Sci U S A (2009) 2.82
Spatiotemporal dynamics of the ER-derived peroxisomal endomembrane system. Int Rev Cell Mol Biol (2009) 0.88
Cell-Nonautonomous Mechanisms Underlying Cellular and Organismal Aging. Int Rev Cell Mol Biol (2015) 0.77
Six plant extracts delay yeast chronological aging through different signaling pathways. Oncotarget (2016) 0.76
A novel approach to the discovery of anti-tumor pharmaceuticals: searching for activators of liponecrosis. Oncotarget (2016) 0.76
Specific changes in mitochondrial lipidome alter mitochondrial proteome and increase the geroprotective efficiency of lithocholic acid in chronologically aging yeast. Oncotarget (2017) 0.76